| Factor | Details |
|---|---|
| Nomenclature | May represent an uncharacterized ORF, deprecated identifier, or typo. |
| Research Stage | Could be a proprietary antibody in early development without public data. |
| Species Specificity | If linked to S. pombe, may lack commercial/research antibodies due to niche applications. |
Re-verify Identifier: Confirm the correct naming convention (e.g., cross-check with genomic databases like PomBase for S. pombe genes).
Explore Alternatives:
If studying fungal systems, consider antibodies against homologous proteins (e.g., SPBC18E5.09 orthologs).
For human research, validate whether SPBC18E5.09c corresponds to a human homolog (e.g., via BLAST alignment).
Collaborative Outreach: Contact antibody vendors (e.g., Abcam, Thermo Fisher) or academic consortia specializing in yeast biology for unpublished data.
While SPBC18E5.09c remains uncharacterized, established workflows for novel antibody development include:
SPBC18E5.09c is classified as a "sequence orphan" protein in Schizosaccharomyces pombe (fission yeast) . Sequence orphans are proteins with no significant sequence similarity to known proteins in other organisms, making their functional characterization particularly challenging. The gene is located within the genome of S. pombe strain 972 / ATCC 24843 and has been identified during genomic sequencing projects . According to genomic analyses, SPBC18E5.09c is one of the 33 open reading frames (ORFs) identified in the mating-type region of S. pombe, with some of these ORFs containing introns . Despite being sequenced, its specific biological function remains largely uncharacterized.
Development of antibodies against sequence orphan proteins like SPBC18E5.09c typically follows these methodological steps:
Antigen design: Computational tools are used to identify immunogenic epitopes specific to the protein sequence.
Recombinant protein expression: The gene (SPBC18E5.09c) is cloned and expressed, often using systems like E. coli, to produce recombinant protein for immunization.
Antibody production: Either monoclonal or polyclonal antibodies can be generated:
Polyclonal: Multiple epitopes are recognized by immunizing animals (typically rabbits) with the purified protein
Monoclonal: Specific hybridoma cell lines are developed to recognize single epitopes
Purification techniques: Affinity chromatography against the recombinant protein is performed to isolate specific antibodies.
Validation: The antibody undergoes extensive validation in wild-type and knockout S. pombe strains to confirm specificity .
Commercial providers like Cusabio offer custom SPBC18E5.09c antibodies with specific validation parameters for S. pombe research applications .
When designing experiments with SPBC18E5.09c antibody, the following controls are methodologically essential:
Negative controls:
SPBC18E5.09c deletion strain (if viable) to confirm antibody specificity
Secondary antibody-only controls to assess non-specific binding
Pre-immune serum controls (for polyclonal antibodies)
Positive controls:
Overexpression strains to confirm detection sensitivity
Recombinant SPBC18E5.09c protein as a Western blot standard
Cross-reactivity controls:
Testing against related S. pombe proteins to confirm specificity
Competition assays with purified antigen
Procedural controls:
Loading controls for Western blots (e.g., α-tubulin)
Protocol-specific controls for immunoprecipitation or immunofluorescence
These controls align with standard research protocols outlined for experimental design in molecular biology studies and should be appropriately documented in research protocols .
Integration of SPBC18E5.09c antibody in phosphoproteomic research involves several methodological approaches:
Immunoprecipitation coupled with mass spectrometry:
SPBC18E5.09c antibody can be used to isolate the protein and its interaction partners
Subsequent mass spectrometry analysis can identify phosphorylation sites and dynamics
This approach has been successfully employed for similar studies in S. pombe as demonstrated in phosphoproteomic networks mediated by Dsk1 kinase
Phosphorylation-specific antibodies:
If phosphorylation sites are identified, phospho-specific antibodies can be developed
These can monitor phosphorylation status under different cellular conditions
Comparative phosphoproteomics:
SPBC18E5.09c antibody can be used for enrichment prior to phosphoproteomic analysis
Changes in phosphorylation patterns can be monitored using quantitative proteomics approaches like SILAC or TMT labeling
This allows for temporal analysis of phosphorylation events during cell cycle or stress responses
Validation of phosphoproteomics data:
Western blotting with SPBC18E5.09c antibody followed by phosphatase treatment can validate mass spectrometry findings
Phospho-mutants can be generated and analyzed to determine functional significance
These approaches are similar to those used in characterizing novel targets and phosphoprotein networks in S. pombe cell cycle regulation .
When investigating sequence orphans like SPBC18E5.09c, consider these methodological principles:
Multi-approach functional characterization:
Phenotypic analysis of deletion mutants under various stress conditions
Localization studies using antibody-based techniques or fluorescent protein tagging
Protein-protein interaction mapping through co-immunoprecipitation followed by mass spectrometry
Temporal expression analysis during different cell cycle stages and meiosis
Evolutionary context analysis:
Structured experimental design:
Integration with genomic context:
Validation through complementary approaches:
Genetic approaches (deletion, overexpression)
Biochemical approaches (antibody-based studies)
Computational predictions (structural modeling)
A systematic approach combining these methodologies increases the likelihood of assigning functions to orphan sequences .
When faced with contradictory experimental results using SPBC18E5.09c antibody, implement this systematic troubleshooting methodology:
Antibody validation reassessment:
Confirm antibody specificity through Western blotting against wild-type and SPBC18E5.09c deletion strains
Test different antibody lots for consistency
Consider epitope mapping to confirm target recognition
Technical parameter optimization:
Systematically vary antibody concentrations, incubation times, and buffer compositions
Test multiple blocking agents to reduce background
Optimize fixation conditions for immunofluorescence applications
Independent validation approaches:
Compare results with tagged versions of SPBC18E5.09c (e.g., GFP or TAP-tagged)
Use orthogonal detection methods (mass spectrometry, RNA analysis)
Cross-validate with alternative antibodies targeting different epitopes of SPBC18E5.09c
Biological context considerations:
Examine whether contradictions might reflect genuine biological variation (cell cycle state, stress responses)
Assess strain background effects by testing in different S. pombe strains
Test for post-translational modifications that might affect antibody recognition
Statistical robustness evaluation:
Increase experimental replication to improve statistical power
Apply appropriate statistical tests for significance assessment
Consider blinded analysis to reduce investigator bias
This structured approach reflects the scientific method applied to antibody-based research problems and aligns with best practices in experimental design .
Optimized immunoprecipitation (IP) with SPBC18E5.09c antibody requires careful methodological consideration:
Cell lysis optimization:
Antibody binding:
Conjugate SPBC18E5.09c antibody to Protein A/G beads or magnetic beads
Alternatively, add 2-5 μg antibody to lysate and incubate (4 hours, 4°C) before adding beads
For co-immunoprecipitation studies, consider gentler detergent conditions (0.1% NP-40)
Wash optimization:
Perform 4-5 washes with decreasing salt concentrations
Include detergent in early washes, remove in later washes
For phosphoprotein studies, include phosphatase inhibitors (sodium orthovanadate, sodium fluoride, and β-glycerophosphate)
Elution strategies:
Use mild elution with antibody competing peptide for native conditions
For denaturing conditions, use SDS sample buffer (95°C, 5 min)
Controls and validation:
Include IgG control IP from same species as SPBC18E5.09c antibody
Perform reciprocal IPs when studying protein interactions
Validate results with Western blotting of input, unbound, and IP fractions
This protocol incorporates methodologies successfully used in S. pombe protein interaction studies, such as those employed in kinetochore protein analysis .
For effective subcellular localization studies using SPBC18E5.09c antibody, implement this methodological framework:
Cell fixation optimization:
Test multiple fixation methods:
Methanol fixation (-20°C, 6 min) for microtubule preservation
3.7% formaldehyde (25°C, 30 min) for general structure preservation
Combined formaldehyde/glutaraldehyde for membrane proteins
Optimize spheroplasting conditions for S. pombe cell wall removal
Immunofluorescence protocol:
Permeabilize cells with 1% Triton X-100 in PBS
Block with BSA (3%) or normal serum (5-10%)
Apply SPBC18E5.09c antibody at optimized concentration (typically 1:100 to 1:1000)
Include co-staining with organelle markers for colocalization studies:
Imaging parameters:
Collect Z-stack images covering entire cell depth
Apply deconvolution algorithms for improved resolution
Use quantitative imaging metrics for comparative analysis
Complementary approaches:
Compare immunofluorescence results with live-cell imaging of GFP-tagged SPBC18E5.09c
Consider super-resolution microscopy techniques for detailed localization
For temporal studies, synchronize cells and examine localization throughout cell cycle
Validation controls:
Include SPBC18E5.09c deletion strains as negative controls
Use pre-immune serum controls
Validate with second antibody targeting different epitope if available
These approaches have been successfully implemented in studies of S. pombe kinetochore proteins during meiosis and can be adapted for SPBC18E5.09c localization studies .
To systematically investigate functions of sequence orphan SPBC18E5.09c, implement this multi-faceted methodology:
Genetic manipulation approaches:
Generate precise gene deletion using CRISPR-Cas9 or homologous recombination
Create conditional mutants (temperature-sensitive, auxin-inducible degron)
Develop overexpression strains using inducible promoters
Perform phenotypic analysis under various conditions (temperature, oxidative stress, DNA damage)
Transcriptomic analysis:
Protein interaction network mapping:
Cell cycle analysis:
Comparative genomics:
Upf1 pathway analysis:
This comprehensive approach integrates methods successfully applied to characterize other S. pombe genes of initially unknown function and follows established principles of experimental design in molecular biology research .
Proper interpretation of Western blot data using SPBC18E5.09c antibody requires this systematic analytical approach:
Signal specificity assessment:
Compare band patterns between wild-type and SPBC18E5.09c deletion strains
Expected molecular weight should be calculated from amino acid sequence accounting for potential post-translational modifications
Multiple bands may indicate:
Degradation products
Post-translational modifications
Alternative splice variants
Cross-reactivity with related proteins
Quantitative analysis methodology:
Normalize target protein signal to loading controls (tubulin, actin)
Use image analysis software for densitometry (ImageJ, Image Lab)
Apply statistical analysis for comparisons across multiple experiments
Express results as fold-change relative to control conditions
Common interpretation challenges:
High background: Optimize blocking conditions, antibody dilution
Weak signal: Increase protein loading, enhance detection methods
Multiple bands: Validate with tagged versions of the protein
Inconsistent results: Standardize lysate preparation and protein quantification
Advanced analytical considerations:
For cell cycle studies, synchronize cultures and collect time points
For stress response studies, include positive controls with known response patterns
For phosphorylation studies, include phosphatase-treated samples as controls
Results reporting standards:
This analytical framework aligns with best practices in protein biochemistry and ensures reliable interpretation of Western blot data using SPBC18E5.09c antibody.
Integrating bioinformatic analysis with experimental data from SPBC18E5.09c antibody studies provides deeper insights through this methodological framework:
Sequence analysis tools:
Secondary structure prediction algorithms (PSIPRED, JPred)
Disorder prediction tools (DisEMBL, PONDR)
Motif detection algorithms (MEME, ELM)
These can identify functional domains despite lack of sequence homology
Structural prediction approaches:
Ab initio protein structure prediction (Rosetta, AlphaFold)
Structural comparison with known proteins (DALI server)
Molecular dynamics simulations to predict functional sites
Integrative data analysis:
Network analysis:
Comparative genomics:
Synteny analysis across different Schizosaccharomyces species
Assessment of selective pressure (dN/dS ratios)
Identification of conserved non-coding regulatory elements
Gene expression correlation analysis:
These bioinformatic approaches complement experimental data by providing context, suggesting mechanisms, and generating testable hypotheses about SPBC18E5.09c function.
To systematically investigate SPBC18E5.09c's potential role in meiosis or cell cycle regulation, implement this experimental framework:
Expression analysis throughout cell cycle and meiosis:
Subcellular localization during meiotic stages:
Phenotypic characterization of deletion mutants:
Measure sporulation efficiency
Assess spore viability through tetrad analysis
Examine chromosome segregation using techniques like:
DAPI staining for nucleus/chromosome visualization
Fluorescent protein-tagged histone markers
Live-cell imaging of GFP-tagged chromosomal loci
Genetic interaction analysis:
Create double mutants with known meiotic regulators
Test interactions with kinetochore components
Screen for synthetic phenotypes with cell cycle checkpoint mutants
Biochemical interaction with cell cycle machinery:
Functional complementation testing:
Replace SPBC18E5.09c with putative functional homologs from related species
Test if phenotypes are rescued
This integrated approach has successfully identified roles for previously uncharacterized proteins in S. pombe meiosis and cell cycle regulation .
When publishing research utilizing SPBC18E5.09c antibody, include this comprehensive validation information:
Antibody specifications:
Source (commercial vendor or laboratory-produced)
Type (monoclonal or polyclonal)
Host species and immunization protocol
Lot number for reproducibility
Epitope information (peptide sequence or region)
Validation experiments:
Western blot demonstrating specificity (wild-type vs. deletion strains)
Immunoprecipitation efficiency assessment
Cross-reactivity testing against related proteins
Peptide competition assays
Side-by-side comparison with epitope-tagged versions of SPBC18E5.09c
Experimental conditions:
Controls documentation:
Primary antibody controls (pre-immune serum, isotype controls)
Secondary antibody-only controls
Loading controls for quantitative comparisons
Positive controls (overexpression strains)
Negative controls (deletion strains)
Quantification methodology:
Software used for image analysis
Statistical methods applied
Normalization procedures
Number of biological and technical replicates
This comprehensive reporting aligns with emerging standards for antibody validation in research and enhances experimental reproducibility .
Researchers can significantly advance knowledge of sequence orphans like SPBC18E5.09c through these methodological contributions:
Comprehensive phenotypic characterization:
Systematic analysis of deletion phenotypes under diverse conditions
Generation of resource strains (tagged versions, conditional alleles)
Deposition of strains in community repositories
Multi-omics data integration:
Structural characterization:
Protein purification protocols optimization
Structural determination via X-ray crystallography, cryo-EM, or NMR
Computational structure prediction validation
Community resource development:
Generation and validation of research-grade antibodies
Development of reporter constructs for functional studies
Creation of CRISPR-Cas9 targeting resources
Data sharing practices:
Deposition of datasets in appropriate repositories:
Proteomics data in ProteomeXchange
RNA-seq data in GEO or ArrayExpress
Protein structures in PDB
Sharing negative results to prevent duplication of effort
Detailed protocols in repositories like protocols.io
Collaborative approaches: